SpareBank 1 Markets has the pleasure of inviting you to a company presentation with Inify Laboratories AB, on Monday 20 June at 13:00 CEST, in connection with the first day of trading on Euronext Growth Oslo the same day.
In connection with the listing, Inify has successfully raised gross proceeds of approximately NOK 150 million by issuing 37,500,000 shares at an issue price of NOK 4. The total amount of shares outstanding in the company following the transaction is 45,236,750, implying a market cap of approximately NOK 181 million. The net proceeds from the Private Placement will be used for the setup of the initial laboratory in Stockholm, Sweden, expanding the team and organization, and for general corporate purposes.
Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling; from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The company originates from ContextVision with nearly 40 years of experience within digital imaging for medical applications and became independent through a spin-off in February 2022.
Participants: Fredrik Palm, CEO
To take part, please use the following link: https://attendee.gotowebinar.com/register/2167702991096533003